Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline

NCT02115256 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped difficult recruitment

Conditions

External Cephalic Version

Interventions

DRUG: Intravenous Terbutaline
DRUG: Intravenous Nitroglycerine

Sponsor

Yaakov Beilin